Startups
SkyDance Vascular has imagined an entirely new category of Peripheral Vascular Access. By deploying the catheter through-the-needle rather than over-the-needle, the OspreyIV is the first and only peripheral vascular access device designed to protect the catheter upon insertion, address historically low insertion related success rates, direct damaging fluids away from the vein wall during infusion, and create a new level of safety against needle stick injury.
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 11, 2026 | SkyDance Vascular Selected to Exhibit OspreyIV Catheter Systems at Vizient Innovative Technology Exchange | OspreyIV’s proprietary through-the-needle technology addresses key challenges in catheter protection, vessel preservation and needlestick safety The Innovative Technology Exchange provides a platform for healthcare providers to engage with ... |
| Jul 8, 2025 | SkyDance Vascular’s Osprey IV Catheter Systems Recognized for Their Unique Alignment with ANTT® Principles | By fully protecting the catheter from bacteria during its insertion through the skin, we consider the through-the-needle technology in vascular access to represent such an advancement.” — Stephen Rowley, Clinical Director, ANTTDELRAY BEACH,... |
| May 6, 2025 | SkyDance Vascular Gains FDA Clearance for Innovative Osprey Midline Closed IV Catheter System | New Extended Dwell Catheter System Poised to Advance PIVC Patient Safety and Outcomes The amazing strides SkyDance Vascular has made are truly impressive. They continue to offer clinical solutions in a space where true innovation is rare. ”... |
| Apr 18, 2023 | SKYDANCE VASCULAR ANNOUNCES U.S. FDA CLEARANCE AND THE ISSUANCE OF NEW PATENTS FOR THE OSPREYIV CATHETER DELIVERY SYSTEM | Peripheral Vascular Access Re-imagined The latest technology from SkyDance Vascular is designed to improve safety measures for the use of Peripheral Intravenous Catheters (PIVC) The through-the-needle design will be a game changer for inser... |
| Mar 21, 2023 | SKYDANCE VASCULAR PUBLISHES PAPER IN JAVA ON GROUNDBREAKING PERIPHERAL INTRAVENOUS CATHETER (PIVC) DESIGN | Skydance Vascular Study Shows a Reduction in Insertion-Related Contamination in an Ovine Study. The ovine study found that the Osprey PIVC, had superior outcomes compared to a traditional PIVC.” — JAVA DELRAY BEACH, FLORIDA, UNITED STATES, ... |
| Dec 16, 2021 | SkyDance Vascular Secures $3.3 Million in Additional Seed Funding | IV therapy is fundamental to patient care, and improvements in IV access make a significant clinical and financial impact. DELRAY BEACH, Fla. (PRWEB) December 16, 2021 SkyDance Vascular (“SkyDance” or “the Company”), a newly formed medical ... |
| Nov 16, 2021 | SkyDance Vascular Announces Issuance of New U.S. Patent | Osprey peripheral vascular access catheter appears to reduce the opportunity for adverse events resulting from potential infection, vessel trauma, and catheter failure all of which are potential indications of a failure to meet the evidence... |
Reviews 0
FAQ about SkyDance Vascular
What has the press written about SkyDance Vascular?
Parsers VC has collected 8 articles mentioning SkyDance Vascular, among them “SkyDance Vascular Selected to Exhibit OspreyIV Catheter Systems at Vizient Innovative Technology Exchange” (Aug 11, 2026) and “SkyDance Vascular’s Osprey IV Catheter Systems Recognized for Their Unique Alignment with ANTT® Principles” (Jul 8, 2025).
Is SkyDance Vascular still active?
Yes, SkyDance Vascular is active; its latest activity on Parsers VC dates from Sep 22, 2026.